• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Resiniferonol-9,13,14-orthophenyl Acetate

Resiniferonol-9,13,14-orthophenyl Acetate

Product ID R1775
Cas No. 57852-42-3
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $148.70 In stock
5 mg $596.50 In stock
10 mg $1,152.60 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Resiniferonol-9,13,14-orthophenyl acetate (ROPA) is a diterpene vanilloid derivative of resiniferatoxin. In vitro, ROPA induces G1/S phase cell cycle arrest, downregulates expression of cyclin D1, upregulates expression of p21, and induces activation of ERK1/2, JNK1/2, and MAPKs. ROPA may activate PKC, promoting carcinogenesis and acting as a tumor promoter.

Product Info

Cas No.

57852-42-3

Purity

≥98%

Formula

C28H32O6

Formula Wt.

464.56

Chemical Name

Daphnetoxin, 6,7-deepoxy-6,7-didehydro-5-deoxy- 21-dephenyl-21-(phenylmethyl)-

Synonym

ROPA, ROP

Solubility

Soluble in DMSO or ethanol.

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

R1775 MSDS PDF

Info Sheet

R1775 Info Sheet PDF

References

Frey MR, Clark JA, Bateman NW, et al. Cell cycle- and protein kinase C-specific effects of resiniferatoxin and resiniferonol 9,13,14-ortho-phenylacetate in intestinal epithelial cells. Biochem Pharmacol. 2004 May 15;67(10):1873-86. PMID: 15130764.

Geiges D, Meyer T, Marte B, et al. Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents. Biochem Pharmacol. 1997 Mar 21;53(6):865-75. PMID: 9113106.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • M3353

    Minocycline Hydrochloride

    Tetracycline; protein translation inhibitor, MMP i...
    ≥98%
  • D1749

    Demecolcine

    Used to study embryonic cloning; microtubule polym...
    ≥97%
  • B5611

    Boc-RRR-AMC

    Peptide, protease substrate.
    ≥98%
  • M5876

    Motesanib

    VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.
    ≥98%
  • O6805

    Orbifloxacin

    Fluoroquinolone; bacterial DNA gyrase inhibitor.
    ≥98%
  • M185770

    5-Methyltetrahydrofolic Acid

    5-Methyltetrahydrofolic Acid is the racemic form o...
    ≥98%
  • B1545

    Benzalkonium Bromide

    Quaternary ammonium cationic surfactant, dissociat...
    ≥95%
  • B5728

    Bohemine

    Purine derivative; CDK inhibitor.
    ≥98%
  • N5655

    Nonoxynol-9

    Nonoxynol surfactant.
    90-110%
  • I4962

    Isoimperatorin

    Furocoumarin; COX-2 inhibitor.
    ≥98%
  • K1678

    Ketanserin

    5-HT2A antagonist, potential α1-adrenergic antago...
    ≥97%
  • F5870

    N-formyl-Met-Leu-Phe

    Peptide, involved in neutrophil activation; FPR1 a...
    ≥95%
  • P3440

    PIK-293

    p110δ PI3K inhibitor.
    ≥98%
  • R2599

    RGYSLG

    Peptide, represents generic protein kinase active ...
    ≥95%
  • P3348

    Pimecrolimus

    Calcineurin inhibitor, potential TRPV1 agonist.
    ≥99%
  • C0154

    7-Ethyl-10-hydroxycamptothecin

    Camptothecin derivative; topoisomerase I inhibitor...
    ≥98%
  • C9808

    CZC-54252

    LRRK2 inhibitor.
    ≥98%
  • D5753

    Donepezil Hydrochloride

    GSK3 and AChE inhibitor, potential σ1 agonist.
    ≥98%
  • M5753

    Monensin Sodium

    Polyether ionophore, autophagy inhibitor.
    ≥98%
  • R3577

    Ritonavir

    HIV protease inhibitor.
    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only